Download PDFPDF
Stress resilience and cancer risk: a nationwide cohort study
Compose Response

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g.
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Statement of Competing Interests


  • A rapid response is a moderated but not peer reviewed online response to a published article in a BMJ journal; it will not receive a DOI and will not be indexed unless it is also republished as a Letter, Correspondence or as other content. Find out more about rapid responses.
  • We intend to post all responses which are approved by the Editor, within 14 days (BMJ Journals) or 24 hours (The BMJ), however timeframes cannot be guaranteed. Responses must comply with our requirements and should contribute substantially to the topic, but it is at our absolute discretion whether we publish a response, and we reserve the right to edit or remove responses before and after publication and also republish some or all in other BMJ publications, including third party local editions in other countries and languages
  • Our requirements are stated in our rapid response terms and conditions and must be read. These include ensuring that: i) you do not include any illustrative content including tables and graphs, ii) you do not include any information that includes specifics about any patients,iii) you do not include any original data, unless it has already been published in a peer reviewed journal and you have included a reference, iv) your response is lawful, not defamatory, original and accurate, v) you declare any competing interests, vi) you understand that your name and other personal details set out in our rapid response terms and conditions will be published with any responses we publish and vii) you understand that once a response is published, we may continue to publish your response and/or edit or remove it in the future.
  • By submitting this rapid response you are agreeing to our terms and conditions for rapid responses and understand that your personal data will be processed in accordance with those terms and our privacy notice.
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

Other responses

Jump to comment:

  • Published on:
    Stress and Cancer: India being the vulnerable Asian country
    • Biju Soman, Post Graduate Trainee (MHA Program) Department of Public Health, Manipal University, Manipal
    • Other Contributors:
      • Aswathi R Lathika, Lecturer

    Stress resilience and cancer risk: a nationwide cohort study (Journal of Epidemiology and Community Health, Volume 71 Issue 10) was a real eye opener to throw light on a new arena of cancer studies. This could be a serious issue in a developing country like India, where the number of patients diagnosed with cancer is shooting up quite alarmingly[1]. The data of National Institute of Cancer Prevention and Research ( September 2017) highlights that, people living with cancer in India is estimated to be around 2.5 million, more than 7 lakh people are newly diagnosed with cancer every year and 5,56,400 people died in 2016 alone, due to this deadly disease[2]. The burden of Thyroid cancer in India has signalled the health authority as the people suffering from thyroid cancer is more than 10 million in the population of 1.324 billion[3].
    Official statistics reveal that there are only about 2000 oncologists in India to treat 10 million cancer patients and the ratio of oncologists to cancer patients is about 1:5,000, whereas, the US has a ratio of about 1:100. There are only 27 Regional Cancer Centres (RCC) in India, which are funded by Central and State Governments and 300 general hospitals. These institutions with inadequate staff, amalgamated with other constraints like financial burden and supply chain challenges make the treatment of cancer even worse[4].
    The escalating cost of cancer treatment in corporate hospitals have made the treatment a night mare for common...

    Show More
    Conflict of Interest:
    None declared.